Scarica l'app Stockscreener
146.47
0.62%
-0.92
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BIIB Giù?
Forum
Previsione
Frazionamento azionario
Biogen Inc Borsa (BIIB) Ultime notizie
Biogen (NASDAQ:BIIB) Upgraded by StockNews.com to Strong-Buy Rating - MarketBeat
BMO cuts rating on Merck and Biogen, on lack of near term catalyst - MSN
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
Biogen in talks to move to MIT's Volpe development, sources say - NBC Boston
Biogen (NASDAQ:BIIB) Downgraded to Market Perform Rating by BMO Capital Markets - MarketBeat
Biogen stock under pressure as rare disease growth lags, says BMO - Investing.com
Neuroimmunology Drugs Market Key Players AnalysisAB Science - openPR
Biogen Inc. stock outperforms competitors on strong trading day - MarketWatch
Recombinant DNA Technology Market Expected to Reach Huge Growth - openPR
Biogen (NASDAQ:BIIB) Sets New 52-Week LowHere's Why - MarketBeat
Coagulation Factor Deficiency Market Key Players AnalysisPfizer Inc, Grifols, Biogen, Octapharma, Baxter. - openPR
Biogen Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Eli Lilly's Alzheimer's treatment approved in China - Reuters
Eli Lilly's Alzheimer's treatment approved in China (Dec. 17) - Yahoo Canada Finance
Biogen's SWOT analysis: stock outlook amid alzheimer's drug launch and pipeline shifts - Investing.com
Multiple Sclerosis Therapeutics Market to See Booming Growth - openPR
Gene Therapy Market Key Players AnalysisNovartis Ag, Biogen - openPR
Biogen Stock: Is BIIB Underperforming the Healthcare Sector? - Nasdaq
Biogen Stock: Is BIIB Underperforming The Healthcare Sector? - Barchart
Why are Biogen, Pfizer, and GSK Trading at a Discount? - Baystreet.ca
Franklin Resources Inc. Sells 13,723 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen downgraded to Hold by Stifelslower progress than expected - Marketscreener.com
Spinal Muscular Atrophy Market Overall Study Report 2024-2031 | - openPR
Stifel downgrades Biogen on slow Alzheimer’s drug launch, uncertainty ahead - MSN
Biogen Inc. stock rises Monday, still underperforms market - MarketWatch
Netflix, Ford, Biogen: Trending tickers - Yahoo Finance
Biogen (NASDAQ:BIIB) Cut to "Hold" at Stifel Nicolaus - MarketBeat
Analyst recommendations: Biogen, Broadcom, Exxon, UnitedHealth, Tesla, Twilio... - Marketscreener.com
World Investment Advisors LLC Acquires Shares of 5,766 Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Ionis Pharmaceuticals, Inc. announced that it expects to receive $624.972654 million in funding from Biogen Inc. - Marketscreener.com
Quantinno Capital Management LP Lowers Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen (NASDAQ:BIIB) Hits New 12-Month LowShould You Sell? - MarketBeat
Oddo BHF Asset Management Sas Purchases Shares of 7,136 Biogen Inc. (NASDAQ:BIIB) - MarketBeat
CMS Tells MA Plans Not To Exclude Biogen’s Qalsody Because Of Accelerated Approval - Citeline
Biogen Inc. stock underperforms Friday when compared to competitors - MarketWatch
CMS says private Medicare plans can’t automatically deny Biogen’s ALS drug - BioPharma Dive
Biogen Inc. (NASDAQ:BIIB) Shares Bought by Inspire Trust Co. N.A. - MarketBeat
Biogen ALS drug needs to be covered by MA plans, CMS says - MSN
Private Medicare plans must cover Biogen's ALS drug, US agency says - Reuters
Biogen Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Kidney Disease - Biogen
Biogen's SWOT analysis: stock faces leqembi launch hurdles amid pipeline shifts - Investing.com
Is Biogen Inc.'s (NASDAQ:BIIB) Stock Price Struggling As A Result Of Its Mixed Financials? - Yahoo Finance
Saratoga Research & Investment Management Sells 7,071 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Virtu Financial LLC Invests $4.11 Million in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
The Escalator: Biogen, Accent Therapeutics, Xira Therapeutics and more - MM+M Online
Biogen Inc. (NASDAQ:BIIB) Shares Acquired by Geode Capital Management LLC - MarketBeat
Public Employees Retirement System of Ohio Has $10.26 Million Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Nomura Asset Management Co. Ltd. Has $9.56 Million Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Postpartum Depression Treatment Market Size, Trends, Growth, - openPR
Biogen Inc. stock rises Wednesday, still underperforms market - MarketWatch
Hypoxic Ischemic Encephalopathy Market Growth to Accelerate - openPR
Biogen Inc. (NASDAQ:BIIB) Shares Purchased by Y Intercept Hong Kong Ltd - MarketBeat
Biogen reinstated with a Neutral at BofA - Yahoo Finance
EP Wealth Advisors LLC Makes New Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. stock outperforms competitors despite losses on the day - MarketWatch
Oversold Conditions For Biogen (BIIB) - Nasdaq
Bank of America Reaffirms "Neutral" Rating for Biogen (NASDAQ:BIIB) - MarketBeat
Biogen Stock Declines 21.4% in 3 Months: How to Play the Stock - Yahoo Finance
Biogen's head of development sells shares worth $17,293 - Investing.com
Biogen downgraded to hold by Jefferies, Ocrevus royalties cited - MSN
1.83%
1.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):